Cargando…

2253. Comparison of Cardiovascular Risk in Patients Infected With HIV and Hepatitis C

BACKGROUND: HIV and hepatitis C virus (HCV) are independently associated with poorer cardiovascular and metabolic outcomes compared with the general population. Evidence remains mixed on how these contribute to cardiovascular disease (CVD) risk in co-infection. Prior studies mainly studied establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jimmy, Salter, Amber, Presti, Rachel, Korenblat, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252762/ http://dx.doi.org/10.1093/ofid/ofy210.1906

Ejemplares similares

2253. Hospitalist Antibiotic Prescribing Patterns by Hour and Weekday
por: Gray, Joshua H, et al.
Publicado: (2023)

2253. Comparison of Outcomes Between Patients with and without Cystic Fibrosis Treated with Ceftolozane–Tazobactam for Pseudomonas aeruginosa Infections
por: Trisler, Michael J, et al.
Publicado: (2019)

PReS-FINAL-2253: A case series of HIV arthropathy in Cape Town
por: Webb, K, et al.
Publicado: (2013)

The prevalence of ocular Demodex folliculorum in 2253 young males
por: Ye, Qian, et al.
Publicado: (2022)

PB2253: HYPEREOSINOPHILIC SYNDROMES: CARDIAC EMERGENCY IN THE ELDERLY
por: Gougas, Ahlam, et al.
Publicado: (2023)

2253: An analysis of how consumer physical activity monitors (monitors) are used in biomedical research
por: Wright, Stephen P., et al.
Publicado: (2018)

Smoking and Opportunistic Infections Contribute to High Rates of Respiratory Symptoms Among HIV-Infected Smokers
por: Hlatshwayo, Matifadza, et al.
Publicado: (2017)

Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience
por: Payner, Troy D., et al.
Publicado: (2011)

PB2253: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AS A PREDICTOR OF SEVERE COVID-19 ON ADMISSION
por: Ababou, M., et al.
Publicado: (2022)

397. Long-Term Mortality of HIV Patients Following Cryptococcal Infection
por: Hevey, Matthew, et al.
Publicado: (2018)

Statin Utilization Among Human-Immunodeficiency Virus (HIV)-Infected Individuals Based on the 2013 American College of Cardiology and American Heart Association (ACC/AHA) Blood Cholesterol Guideline
por: Non, Lemuel, et al.
Publicado: (2017)

2225. Acute Hepatitis C Virus Infections in HIV-Infected Persons in the Era of Direct-Acting Antiviral Therapy
por: Cartwright, Emily J, et al.
Publicado: (2018)

1292. Integrating HIV and Hepatitis C Screening in a High-Risk Emergency Department Population
por: Chechi, Tasleem, et al.
Publicado: (2019)

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
por: Chaudhury, Chloe, et al.
Publicado: (2017)

976. Development and Validation of a Risk Score for Predicting Cardiovascular Events in HIV-Infected Patients
por: Karanika, Styliani, et al.
Publicado: (2019)

1757. Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes
por: Crossman, Hayley, et al.
Publicado: (2019)

Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
por: Korten, Volkan, et al.
Publicado: (2017)

Stroke Outcomes Among HIV-infected Patients in a Large, Urban, Tertiary Hospital in the USA, 1999–2016
por: McBride, Darrell, et al.
Publicado: (2017)

Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of New Direct-Acting Antiviral Therapy
por: Deering, Caytlin, et al.
Publicado: (2017)

68. Comparison of Cardiovascular Risk Assessment Calculators in the US Military HIV Natural History Study
por: Wyatt, Andrew C, et al.
Publicado: (2021)

1589 Incidence and Risk factors of Hepatitis C Virus Infection among HIV Patients in a large HIV Clinic in South Korea
por: Lee, Shinwon, et al.
Publicado: (2014)

355. Barriers for Hepatitis C Elimination in HIV/HCV Coinfected Patients
por: Espinoza, Joe, et al.
Publicado: (2019)

362. Hepatitis C Virus (HCV) Co-Infection in Women Living with Human Immunodeficiency Virus (HIV) in Northwest Louisiana
por: Mohammed, Ethar, et al.
Publicado: (2019)

923. Long-term Mortality after Histoplasma Infection in People Living with HIV
por: Cherabie, Joseph, et al.
Publicado: (2020)

Correction: Silva et al. Precision Technologies to Address Dairy Cattle Welfare: Focus on Lameness, Mastitis and Body Condition. Animals 2021, 11, 2253
por: Silva, Severiano R., et al.
Publicado: (2022)

Cystatin C and cardiovascular risk in HIV infected patients
por: Falasca, Katia, et al.
Publicado: (2010)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

938. Identifying Gaps in the Treatment of Hepatitis C in Patients Co-Infected with HIV in Edmonton, Alberta
por: Savaryn, Bohdan, et al.
Publicado: (2020)

A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment
por: George, Nerissa, et al.
Publicado: (2019)

2254. Adherence to Cardiovascular Disease Risk Management Guidelines Amongst HIV Providers at an Academic HIV Clinic
por: Veltman, Jennifer, et al.
Publicado: (2018)

2233. Hepatitis C Eradication: Who Is Being Left Behind in the HIV Population?
por: Jain, Mamta K, et al.
Publicado: (2018)

338. Patients Living with HIV Infection Are Less Likely to Receive the Correct Intensity of Statin Therapy for Cardiovascular Disease Risk Reduction
por: Schafer, Jason J, et al.
Publicado: (2019)

1379. Evaluation of Cardiovascular Disease Risk among People Living with HIV in Lebanon
por: Helou, Remie El, et al.
Publicado: (2023)

2229. Low Hepatitis C Virus Reinfection Rates After Sustained Viral Response in HIV Co-infected Patients in Houston, Texas
por: Offor, Lynda, et al.
Publicado: (2018)

The impact of HTLV-1 infection on clinical and immunological outcomes in patients coinfected with HIV and hepatitis C virus
por: Bahia, Fabianna, et al.
Publicado: (2011)

Using Whole Genome Sequencing to Trace, Control and Characterize a Hospital Infection of IMP-4-Producing Klebsiella pneumoniae ST2253 in a Neonatal Unit in a Tertiary Hospital, China
por: Bai, Yuanyuan, et al.
Publicado: (2021)

358. HIV Infection and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus (HBV) Co-infection: a Propensity Score-matched Cohort Study
por: Lui, Grace, et al.
Publicado: (2019)

2049. Pneumocystis jiroveci Detection by Nested PCR in HIV-Infected Peruvian Patients
por: Camargo, Jimmy, et al.
Publicado: (2018)

Mental health outcomes for individuals with chronic hepatitis C infection.
por: Thompson, William W., et al.
Publicado: (2019)

293. Hepatitis C is now a Millennial Disease in Response to the Opioid Crisis: A Demographic Shift in Hepatitis C Infection
por: Rose, Michelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7lc2313hrlpla2dhkknqh9ft4h